Nervous system adverse responses to topiramate in the treatment of neuropsychiatric disorders

Bibliography

• Johnson BA, Rosenthal N, Capece JA, Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 2007;298(14):1641-51
   PubMed Web of Science ®Google Scholar
• Loew TH, Nickel MK, Muehlbacher M, Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study. J Clin Psychopharmacol 2006;26(1):61-6
   PubMed Web of Science ®Google Scholar
• Nickel MK, Nickel C, Kaplan P, Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study. Biol Psychiatry 2005;57(5):495-9
   PubMed Web of Science ®Google Scholar
• Nickel MK, Nickel C, Mitterlehner FO, Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study. J Clin Psychiatry 2004;65(11):1515-9
   PubMed Web of Science ®Google Scholar
• Frima N, Grunewald RA. A double-blind, placebo-controlled, crossover trial of topiramate in essential tremor. Clin Neuropharmacol 2006;29(2):94-6
   PubMed Web of Science ®Google Scholar
• Ondo WG, Jankovic J, Connor GS, Topiramate in essential tremor: a double-blind, placebo-controlled trial. Neurology 2006;66(5):672-7
   PubMed Web of Science ®Google Scholar
• McElroy SL, Arnold LM, Shapira NA, Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry 2003;160(2):255-61
   PubMed Web of Science ®Google Scholar
• Van Ameringen M, Mancini C, Patterson B, Bennett M. Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case series. Depress Anxiety 2006;23(1):1-5
   PubMed Web of Science ®Google Scholar
• Muehlbacher M, Nickel MK, Kettler C, Topiramate in treatment of patients with chronic low back pain: a randomized, double-blind, placebo-controlled study. Clin J Pain 2006;22(6):526-31
   PubMed Web of Science ®Google Scholar
• Zaccara G, Gangemi PF, Cincotta M. Central nervous system adverse effects of new antiepileptic drugs. A meta-analysis of placebo-controlled studies. Seizure 2008;17(5):405-21
   PubMed Web of Science ®Google Scholar
• Brandes JL, Saper JR, Diamond M, Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004;291(8):965-73
   PubMed Web of Science ®Google Scholar
• Diener HC, Tfelt-Hansen P, Dahlof C, Topiramate in migraine prophylaxis-results from a placebo-controlled trial with propranolol as an active control. J Neurol 2004;251(8):943-50
   PubMed Web of Science ®Google Scholar
• Mei D, Capuano A, Vollono C, Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study. Neurol Sci 2004;25(5):245-50
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Hulihan J, Karim MR, Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study. Clin Ther 2006;28(7):1002-11
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Neto W, Schmitt J, Jacobs D. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004;61(4):490-5
   PubMed Web of Science ®Google Scholar
• Silvestrini M, Bartolini M, Coccia M, Topiramate in the treatment of chronic migraine. Cephalalgia 2003;23(8):820-4
   PubMed Web of Science ®Google Scholar
• Luykx J, Mason M, Ferrari MD, Carpay J. Are migraineurs at increased risk of adverse drug responses? A meta-analytic comparison of topiramate-related adverse drug reactions in epilepsy and migraine. Clin Pharmacol Ther 2009;85(3):283-8
   PubMed Web of Science ®Google Scholar
• Rehm J, Mathers C, Popova S, Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009;373(9682):2223-33
   PubMed Web of Science ®Google Scholar
• WHO. Global Status report on Alcohol 2004. Geneva: World Health Organization 2004
   Google Scholar
• Baltieri DA, Daro FR, Ribeiro PL, de Andrade AG. Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction 2008;103(12):2035-44
   PubMed Web of Science ®Google Scholar
• Johnson BA, Ait-Daoud N, Akhtar FZ, Ma JZ. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Arch Gen Psychiatry 2004;61(9):905-12
   PubMed Web of Science ®Google Scholar
• Johnson BA, Ait-Daoud N, Bowden CL, Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 2003;361(9370):1677-85
   PubMed Web of Science ®Google Scholar
• Johnson BA, Rosenthal N, Capece JA, Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Arch Intern Med 2008;168(11):1188-99
   PubMed Web of Science ®Google Scholar
• Benito-Leon J, Louis ED. Essential tremor: emerging views of a common disorder. Nat Clin Pract Neurol 2006;2(12):666-78, quiz 2p following 91
   PubMedGoogle Scholar
• Connor GS. A double-blind placebo-controlled trial of topiramate treatment for essential tremor. Neurology 2002;59(1):132-4
   PubMed Web of Science ®Google Scholar
• Connor GS, Edwards K, Tarsy D. Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials. Clin Neuropharmacol 2008;31(2):97-103
   PubMed Web of Science ®Google Scholar
• Galvez-Jimenez N, Hargreave M. Topiramate and essential tremor. Ann Neurol 2000;47(6):837-8
   PubMed Web of Science ®Google Scholar
• Lieb K, Zanarini MC, Schmahl C, Borderline personality disorder. Lancet 2004;364(9432):453-61
   PubMed Web of Science ®Google Scholar
• Claudino AM, de Oliveira IR, Appolinario JC, Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder. J Clin Psychiatry 2007;68(9):1324-32
   PubMed Web of Science ®Google Scholar
• McElroy SL, Hudson JI, Capece JA, Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. Biol Psychiatry 2007;61(9):1039-48
   PubMed Web of Science ®Google Scholar
• McElroy SL, Shapira NA, Arnold LM, Topiramate in the long-term treatment of binge-eating disorder associated with obesity. J Clin Psychiatry 2004;65(11):1463-9
   PubMed Web of Science ®Google Scholar
• Hedges DW, Reimherr FW, Hoopes SP, Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures. J Clin Psychiatry 2003;64(12):1449-54
   PubMed Web of Science ®Google Scholar
• Hoopes SP, Reimherr FW, Hedges DW, Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures. J Clin Psychiatry 2003;64(11):1335-41
   PubMed Web of Science ®Google Scholar
• Nickel C, Tritt K, Muehlbacher M, Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial. Int J Eat Disord 2005;38(4):295-300
   PubMed Web of Science ®Google Scholar
• Lipton RB, Stewart WF, Diamond S, Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41(7):646-57
   PubMed Web of Science ®Google Scholar
• Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). J Headache Pain 2005;6(6):429-40
   PubMedGoogle Scholar
• Lindley SE, Carlson EB, Hill K. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. J Clin Psychopharmacol 2007;27(6):677-81
   PubMed Web of Science ®Google Scholar
• Bussone G, Diener HC, Pfeil J, Schwalen S. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Int J Clin Pract 2005;59(8):961-8
   PubMed Web of Science ®Google Scholar